3b6e

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 3: Line 3:
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[3b6e]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3B6E OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3B6E FirstGlance]. <br>
<table><tr><td colspan='2'>[[3b6e]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3B6E OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3B6E FirstGlance]. <br>
-
</td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NA:SODIUM+ION'>NA</scene><br>
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr>
-
<tr><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">IFIH1, MDA5, RH116 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])</td></tr>
+
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">IFIH1, MDA5, RH116 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])</td></tr>
-
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3b6e FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3b6e OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3b6e RCSB], [http://www.ebi.ac.uk/pdbsum/3b6e PDBsum]</span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3b6e FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3b6e OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3b6e RCSB], [http://www.ebi.ac.uk/pdbsum/3b6e PDBsum]</span></td></tr>
-
<table>
+
</table>
== Disease ==
== Disease ==
[[http://www.uniprot.org/uniprot/IFIH1_HUMAN IFIH1_HUMAN]] Genetic variation in IFIH1 is associated with diabetes mellitus insulin-dependent type 19 (IDDM19) [MIM:[http://omim.org/entry/610155 610155]]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.<ref>PMID:16699517</ref> Note=IFIH1 is the CADM-140 autoantigen, involved in clinically amyopathic dermatomyositis (CADM). This is a chronic inflammatory disorder that shows typical skin manifestations of dermatomyositis but has no or little evidence of clinical myositis. Anti-CADM-140 antibodies appear to be specific to dermatomyositis, especially CADM. Patients with anti-CADM-140 antibodies frequently develop life-threatening acute progressive interstitial lung disease (ILD).<ref>PMID:19565506</ref> <ref>PMID:20015976</ref>
[[http://www.uniprot.org/uniprot/IFIH1_HUMAN IFIH1_HUMAN]] Genetic variation in IFIH1 is associated with diabetes mellitus insulin-dependent type 19 (IDDM19) [MIM:[http://omim.org/entry/610155 610155]]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.<ref>PMID:16699517</ref> Note=IFIH1 is the CADM-140 autoantigen, involved in clinically amyopathic dermatomyositis (CADM). This is a chronic inflammatory disorder that shows typical skin manifestations of dermatomyositis but has no or little evidence of clinical myositis. Anti-CADM-140 antibodies appear to be specific to dermatomyositis, especially CADM. Patients with anti-CADM-140 antibodies frequently develop life-threatening acute progressive interstitial lung disease (ILD).<ref>PMID:19565506</ref> <ref>PMID:20015976</ref>
Line 26: Line 26:
</StructureSection>
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
-
[[Category: Arrowsmith, C H.]]
+
[[Category: Arrowsmith, C H]]
-
[[Category: Berg, S Van Den.]]
+
[[Category: Berg, S Van Den]]
-
[[Category: Berglund, H.]]
+
[[Category: Berglund, H]]
-
[[Category: Busam, R D.]]
+
[[Category: Busam, R D]]
-
[[Category: Collins, R.]]
+
[[Category: Collins, R]]
-
[[Category: Dahlgren, L G.]]
+
[[Category: Dahlgren, L G]]
-
[[Category: Edwards, A M.]]
+
[[Category: Edwards, A M]]
-
[[Category: Flodin, S.]]
+
[[Category: Flodin, S]]
-
[[Category: Flores, A.]]
+
[[Category: Flores, A]]
-
[[Category: Graslund, S.]]
+
[[Category: Graslund, S]]
-
[[Category: Hammarstrom, M.]]
+
[[Category: Hammarstrom, M]]
-
[[Category: Holmberg-Schiavone, L.]]
+
[[Category: Holmberg-Schiavone, L]]
-
[[Category: Johansson, I.]]
+
[[Category: Johansson, I]]
-
[[Category: Kallas, A.]]
+
[[Category: Kallas, A]]
-
[[Category: Karlberg, T.]]
+
[[Category: Karlberg, T]]
-
[[Category: Kotenyova, T.]]
+
[[Category: Kotenyova, T]]
-
[[Category: Lehtio, L.]]
+
[[Category: Lehtio, L]]
-
[[Category: Moche, M.]]
+
[[Category: Moche, M]]
-
[[Category: Nilsson, M E.]]
+
[[Category: Nilsson, M E]]
-
[[Category: Nordlund, P.]]
+
[[Category: Nordlund, P]]
-
[[Category: Nyman, T.]]
+
[[Category: Nyman, T]]
-
[[Category: Persson, C.]]
+
[[Category: Persson, C]]
-
[[Category: SGC, Structural Genomics Consortium.]]
+
[[Category: Structural genomic]]
-
[[Category: Sagemark, J.]]
+
[[Category: Sagemark, J]]
-
[[Category: Svensson, L.]]
+
[[Category: Svensson, L]]
-
[[Category: Thorsell, A G.]]
+
[[Category: Thorsell, A G]]
-
[[Category: Tresaugues, L.]]
+
[[Category: Tresaugues, L]]
-
[[Category: Weigelt, J.]]
+
[[Category: Weigelt, J]]
-
[[Category: Welin, M.]]
+
[[Category: Welin, M]]
[[Category: Antiviral defense]]
[[Category: Antiviral defense]]
[[Category: Atp-binding]]
[[Category: Atp-binding]]
Line 69: Line 69:
[[Category: Phosphorylation]]
[[Category: Phosphorylation]]
[[Category: Sgc]]
[[Category: Sgc]]
-
[[Category: Structural genomic]]
 
-
[[Category: Structural genomics consortium]]
 

Revision as of 11:32, 20 January 2015

Crystal structure of human DECH-box RNA Helicase MDA5 (Melanoma differentiation-associated protein 5), DECH-domain

3b6e, resolution 1.60Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools